Answer
Tepotinib targets abnormal MET signalling, so a validated test must confirm a relevant MET exon 14 skipping alteration.
Sources for this answer
- TEPMETKO 225 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.